Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease.
de la Monte SM.
Drugs. 2012 Jan 1;72(1):49-66. doi: 10.2165/11597760-000000000-00000. Review.
Related citations
Current and emerging drug treatment options for Alzheimer's disease: a systematic review.
Herrmann N, Chau SA, Kircanski I, Lanctôt KL.
Drugs. 2011 Oct 22;71(15):2031-65. doi: 10.2165/11595870-000000000-00000. Review.
Current and Emerging Drug Treatment Options for Alzheimer's Disease: A Systematic Review.
Drugs. 2011 Oct 4. [Epub ahead of print]
Therapeutic potential of copper chelation with triethylenetetramine in managing diabetes mellitus and Alzheimer's disease.
Cooper GJ.
Drugs. 2011 Jul 9;71(10):1281-320. doi: 10.2165/11591370-000000000-00000. Review.
Rivastigmine transdermal patch: a review of its use in the management of dementia of the Alzheimer's type.
Dhillon S.
Drugs. 2011 Jun 18;71(9):1209-31. doi: 10.2165/11206380-000000000-00000. Review.
Intravenous immunoglobulins as a treatment for Alzheimer's disease: rationale and current evidence.
Dodel R, Neff F, Noelker C, Pul R, Du Y, Bacher M, Oertel W.
Drugs. 2010 Mar 26;70(5):513-28. doi: 10.2165/11533070-000000000-00000. Review.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on